pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Prednisolone
drug
save

prednisolone

Marketedupdated 3mo ago
by Teva Pharmaceuticals USA Inc
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval74 co-mentions · 37 sources
  • drugPRED MILD74 co-mentions · 37 sources
  • drugprednisolone acetate37 co-mentions · 37 sources
  • drugFarmiblastina1 co-mentions · 1 sources
  • drugCHOP [cyclophosphamide + doxorubicin + vincristine + prednisolone]1 co-mentions · 1 sources
  • companyCity of Hope1 co-mentions · 1 sources
  • tagOncology1 co-mentions · 1 sources
  • tagDLBCL1 co-mentions · 1 sources

indications

investigational
Multiple SclerosisIBD (Crohn's + UC)Rheumatoid ArthritisPsoriasisLupusAsthmaPulmonary Fibrosis

all catalysts(0)

nothing on the calendar yet

Trials studying prednisolone

  • phase3A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)recruitingn=960
  • phase4A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Diseaserecruitingn=92
  • phase3A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphomarecruitingn=822
  • phase2A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)recruitingn=594
  • phase3A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosumrecruitingn=90
  • phase3A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancerrecruitingn=800
  • phase3A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)recruitingn=1,046
  • phase3A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritisactive not recruitingn=271
more trials →

News(0)

no news has mentioned this drug yet

brand
Prednisolone
generic
prednisolone [INN]
indication
Allergic Conjunctivitis
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 36m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?